News Sentiment

PLSE sentiment intelligence

Pulse Biosciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 52 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 26.29 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 52

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-10.0% over one week, +7.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

PULSE BIOSCIENCES ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction -10.0% Price reacting lower
Trend fit Trend active 7.9% over four weeks
Fair value 76.7% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 38
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 52
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 12
Market source 7
TradingKey 5
Business Wire 5
Stock Titan 4
MT Newswires 3
Moomoo 2
Stock Traders Daily 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 12
Analyst action 5
Balance sheet 3
Regulatory and legal 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-52 of 52
Stock Titan Direct company coverage

Pulse Biosciences (PLSE) director awarded stock options for 44,504 shares

Pulse Biosciences director Mahkam Zanganeh has been awarded two stock option grants totaling 44,504 shares (14,504 and 30,000 shares) at an exercise price of $26.89 per share, expiring on June 11, 2036. The 14,504-share option vests monthly over one year starting July 11, 2026, w

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 02:09
Source
Stock Titan